Growing Adoption of Proteomics in Life Sciences Research to Drive the Global Proteomics Market, According to New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Proteomics markets. The global Proteomics market is projected to reach US$10.8 billion by 2018, driven by the growing adoption of Proteomics in life sciences research. Additionally, as the genomic data gives out limited information about the role of the proteins in the biochemical pathways, research activities are steadily shifting from genomes to high throughput and large-scale analysis of Proteomes, leading to evolution of technologically advanced protein research tools. Additionally, the market is also expected to gain from the research efforts and initiatives focused on Proteomics in countries such as the US, UK, Canada, China, and Japan.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Proteomics: A Global Strategic Business Report

San Jose, CA (PRWEB) October 16, 2012

Follow us on LinkedIn – Proteomics is a critical technology due to its ability to facilitate mass screening of proteins. Presently, proteomics has risen from the point where genomics studies plateaued. A paradigm shift continues from genomics to proteomics due to change in focus from genes to proteins. This shift paves way for technological advancements assisting drug discovery researchers by offering added sensitivity, increased throughput, and increased resolution from traditional protein research tools. Additionally, the shift in focus also enhances the number of assays requiring protein sample preparation. Also, rapid industrialization of research in biological proteomics is expected to propel the expansion of sample preparation technologies. An increase in funding and facilities for these studies plays a significant role in the growth of proteomics.

In the post-genomic era, proteomic technologies are expected to play a crucial part in the field of medicine, molecular diagnostics, and drug discovery. In the field of drug discovery, proteomics-based technologies are gaining ground due to the ability of proteomics to provide superior understanding of the pathomechanisms of human diseases. As the importance of proteomics technologies continues to increase in the drug discovery platform, it is expected that the number of samples analyzed and assays performed would rise significantly, while the demand for sample preparation products would also grow substantially. Subsequently, the manufacturers providing solutions capable of simplifying sample preparation procedures are expected to gain a significant share of the rapidly expanding proteomics market. In the upcoming years, proteomic technologies market is expected to witness the maximum expansion and development, with neurological disorders and cancer likely to emerge as the key application areas.

Some of the most commonly employed technologies include protein analysis by mass spectrometry, and 2D gel electrophoresis for separation of proteins. Going forwards, it is expected that Mass spectrometry (MS) is likely to assume a greater role, largely due to the benefits offered in terms of resolution and accuracy. Of late, hybrid Mass spectrometry instrument (LC MS/MS), which offer superior accuracy and sensitive analysis of peptides, are increasing in the market. For instance, recently introduced mass spectrometry platforms have improved the performance of ion inlets and transfer optics, thereby improving the sensitivity factor of MS to a greater extent. Also, it has been observed that MS platforms have also worked on the sequencing speed as well, thereby resulting in the identification of greater number of proteins from an undefined sample. Therefore, given the present situation, MS has become a pivotal tool for biologists and biochemists to gain better insights into the various molecular mechanisms regulating cells.

However, given the advancements in proteomics technologies, the biggest challenge is the integration of proteomics data and equipment. In an effort to provide optimum value and eliminate incompatibilities, vendors need to address these issues at the earliest. Corroboration of information and improvement in software are becoming vital, with increasing complexity of proteomics and continuous evolution of the proteomics technologies in the rapidly developing market. Therefore, most of the enhancement in software is visible in visualization and data mining, knowledge-based approaches to crystallization, and automation of data acquisition and analysis.

The United States and Europe represent the predominant proteomics markets, as stated by the new market research report on Proteomics. The US proteomics market benefits from the vast diversity and scale of operations of the academics sector. However, in the ensuing years, China is expected to become a formidable force in the proteomics market. This can be substantiated by the fact that presently Chinese researchers are undertaking various initiatives which could put the country at the forefront internationally in the field of proteomics. Also, impressive investments are rejuvenating proteomics-based research organizations in China, which is further expected to add impetus to the proteomics market.

The study of proteomics cannot be done in isolation; it works in conjunction with complementary industries such as bioinformatics and biotechnology. Hence, several companies actively participating in the value chain of proteomics, which include bioinformatics companies, instrument manufacturers, service providers, laboratory product suppliers, and other companies related to biotechnology. Major players profiled in the report include Agilent Technologies, Bio-Rad Laboratories, Bruker Daltonics Inc., Dionex Corporation, GE Healthcare, Life Technologies Corporation, Millipore Corp., PerkinElmer, Proteome Systems Ltd., Shimadzu Biotech, and Thermo Fisher Scientific, among others.

The research report titled “Proteomics: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the proteomics market, current market trends, key growth drivers, proteomic technologies, product introductions/innovations, strategic corporate initiatives, and profiles of major/niche global and regional market players. The study analyzes market data and analytics in terms of value sales for the years 2010 through 2018 for the geographic regions including the United States, Canada, Japan, Europe, and Rest of World. Also, a six-year (2004-2009) historic analysis is provided for additional perspective.

For more details about this comprehensive market research report, please visit –
http://www.strategyr.com/Proteomics_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###


Contact

Attachments